US EditionColossal adds funding as it makes strides to revive dodo bird
Colossal Biosciences raised $120 million, extending its Series C to $320 million and valuing the company at $10.3 billion to advance dodo bird de-extinction.
- Colossal Biosciences announced on September 17 that its scientists successfully grew pigeon primordial germ cells, a key step toward dodo revival in Texas.
- The achievement follows the company's 2021 founding and aims to use gene-edited surrogates like chickens to breed dodos, with critics noting limits to true resurrection.
- The company plans to inject edited cells from the Nicobar pigeon, the dodo's closest relative, into surrogate chickens and also targets the extinct moa bird.
- Colossal has raised $120 million more in funding, boosting its valuation past $10.3 billion, with CEO Ben Lamm describing the team's achievement as a major step forward for efforts to bring back the dodo.
- This progress supports plans for dodo rewilding in Mauritius, while the firm’s broader goals include advancing avian conservation and accelerating de-extinction projects.
18 Articles
18 Articles
Startup Gives Its Timeline for Breeding Actual Dodo Birds
To "go the way of the dodo" could come to mean something very different if Colossal Biosciences has its way. The Texas startup—founded in 2021 and bent on seeing the "de-extinction" of certain species —claims it has made a key advancement in its efforts to resurrect the bird , which...
Colossal Biosciences raises $120M to revive the Dodo bird and other extinct species, hits $10.3B valuation - Tech Startups
The dodo bird, last seen in the 17th century before Dutch sailors hunted it into oblivion, may soon waddle its way back into existence. Dallas-based Colossal Biosciences has secured an extra $120 million to push forward its headline-grabbing de-extinction projects—most […] The post Colossal Biosciences raises $120M to revive the Dodo bird and other extinct species, hits $10.3B valuation first appeared on Tech Startups.
Genetic bioengineering firm steps closer to reviving the dodo
The latest development out of Colossal Biosciences — the genetic engineering company trying to bring animals back from extinction that Semafor has covered before — is that it has successfully grown pigeon primordial germ cells, or cells that become sperm or eggs, the company announced Wednesday. It is a historic step in bringing the dodo bird, extinct for more than 360 years, back to life.Scientists tested more than 300 combinations of growth fa…
Coverage Details
Bias Distribution
- 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
